Pharmacological and psychological treatment of depression and anxiety among hemodialyzed patients - a review.

Postepy psychiatrii neurologii Pub Date : 2024-06-01 Epub Date: 2024-07-10 DOI:10.5114/ppn.2024.141377
Aleksandra Ćwiek
{"title":"Pharmacological and psychological treatment of depression and anxiety among hemodialyzed patients - a review.","authors":"Aleksandra Ćwiek","doi":"10.5114/ppn.2024.141377","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>An overview of the current pharmacological treatment and psychosocial interventions, such as cognitive-behavioral therapy and breathing exercises, for depression and anxiety among hemodialyzed patients (HD).</p><p><strong>Views: </strong>Depression and anxiety are common problems among HD patients, influencing their mortality and morbidity; however, they are often under-recognized and under-treated. Even though the topic is attracting more scientific attention there are still only few studies about methods of treatment for those disorders. Moreover, there are no clear guidelines on pharmacological therapy, which may prove to be difficult among patients with decreased renal function. Psychological interventions such as cognitive-behavioral therapy may be useful in treatment of these mental disorders among HD patients, though reports on the effects of such interventions are scarce.</p><p><strong>Conclusions: </strong>This review outlines some of the current approaches to the treatment of mental disorders among HD patients that use both antidepressants and therapeutic methods. There is an urgent need for randomized clinical trials of both psychosocial and pharmacological interventions in treatment of depressive and anxiety disorders. Currently, both methods seem to be useful; however, they should be implemented with caution until clear guidelines are developed.</p>","PeriodicalId":74481,"journal":{"name":"Postepy psychiatrii neurologii","volume":"33 2","pages":"98-102"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11304225/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Postepy psychiatrii neurologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ppn.2024.141377","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: An overview of the current pharmacological treatment and psychosocial interventions, such as cognitive-behavioral therapy and breathing exercises, for depression and anxiety among hemodialyzed patients (HD).

Views: Depression and anxiety are common problems among HD patients, influencing their mortality and morbidity; however, they are often under-recognized and under-treated. Even though the topic is attracting more scientific attention there are still only few studies about methods of treatment for those disorders. Moreover, there are no clear guidelines on pharmacological therapy, which may prove to be difficult among patients with decreased renal function. Psychological interventions such as cognitive-behavioral therapy may be useful in treatment of these mental disorders among HD patients, though reports on the effects of such interventions are scarce.

Conclusions: This review outlines some of the current approaches to the treatment of mental disorders among HD patients that use both antidepressants and therapeutic methods. There is an urgent need for randomized clinical trials of both psychosocial and pharmacological interventions in treatment of depressive and anxiety disorders. Currently, both methods seem to be useful; however, they should be implemented with caution until clear guidelines are developed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血液透析患者抑郁和焦虑的药物和心理治疗 - 综述。
目的:概述目前针对血液透析患者(HD)抑郁和焦虑的药物治疗和心理干预措施,如认知行为疗法和呼吸练习:抑郁和焦虑是血液透析患者的常见问题,影响着他们的死亡率和发病率;然而,这些问题往往未得到充分认识和治疗。尽管这一问题正引起越来越多的科学界关注,但有关这些疾病治疗方法的研究仍然很少。此外,在药物治疗方面也没有明确的指导方针,对于肾功能减退的患者来说,药物治疗可能会比较困难。认知行为疗法等心理干预可能有助于治疗 HD 患者的这些精神障碍,但有关此类干预效果的报告很少:本综述概述了目前使用抗抑郁药物和治疗方法治疗 HD 患者精神障碍的一些方法。目前迫切需要对治疗抑郁和焦虑症的社会心理干预和药物干预进行随机临床试验。目前,这两种方法似乎都很有用,但在制定明确的指导方针之前,应谨慎实施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Pathology and treatment methods in pantothenate kinase-associated neurodegeneration. Secretome - the role of extracellular vesicles in the pathogenesis and therapy of neurodegenerative diseases. Severe headache as the first presentation of post-COVID-19 brain and spinal cord injury resembling neurosarcoidosis. The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review. Communication issues in co-occurring ADHD and autism spectrum disorders. Evaluative approaches and targeted interventions: mini review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1